Surgical Hemostats Market Report 2026
Surgical Hemostats Market Report 2026
Global Outlook – By Product Type (Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types), By Formulation (Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats), By Application (Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Surgical Hemostats Market Overview
• Surgical Hemostats market size has reached to $3.93 billion in 2025 • Expected to grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: The Rise In Trauma Cases Drives The Growth Of The Market Due To Increasing Surgical Interventions • Market Trend: Advancements In Room-Temperature Hemostatic Patch Technologies Improve Surgical Bleeding Control And Workflow Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Surgical Hemostats Market?
Surgical hemostats are specialized instruments or agents used during surgical procedures to control bleeding by clamping blood vessels or promoting clot formation. They help maintain a clear surgical field and reduce blood loss, ensuring better visibility and safety during operations. The main product types of surgical hemostats are topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are hemostatic agents applied directly to bleeding sites during surgery to promote clot formation by converting fibrinogen to fibrin using thrombin. These are available in various formulations, such as matrix and gel hemostats, sponge hemostats, sheet and pad hemostats, and powder hemostats. They are used across a range of applications, including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries, and others. These products serve multiple end users, such as hospitals, ambulatory surgical centers, specialty clinics, and others.
What Is The Surgical Hemostats Market Size and Share 2026?
The surgical hemostats market size has grown strongly in recent years. It will grow from $3.93 billion in 2025 to $4.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising surgical procedures, demand for blood loss management, advancement in surgical instruments, increase in hospital infrastructure, awareness about patient safety.What Is The Surgical Hemostats Market Growth Forecast?
The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.Global Surgical Hemostats Market Segmentation
1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types 2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats 3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications 4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments: 1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge 2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables 3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets 4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives 5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin 6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin 7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived AgentsWhat Is The Driver Of The Surgical Hemostats Market?
The rising incidence of trauma cases is expected to propel the growth of the surgical hemostats market going forward. Trauma refers to a physical injury or emotional shock caused by a distressing or harmful event, which can affect a person's body or mind. The rising incidence of trauma cases is primarily due to an increase in road traffic accidents, which lead to severe injuries requiring urgent medical intervention. Surgical hemostats help control bleeding quickly and effectively during trauma cases, minimizing blood loss and stabilizing patients for further treatment. For instance, in 2023, according to the Wisconsin Department of Health Services, a US-based government agency, 2023 traumatic injuries caused by assault rose by 3% compared to 2022, increasing from 1,544 cases to 1,584 cases. Therefore, the rising incidence of trauma cases is driving the growth of the surgical hemostats industry.Key Players In The Global Surgical Hemostats Market
Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbHGlobal Surgical Hemostats Market Trends and Insights
Major companies operating in the surgical hemostat market are focusing on developing advanced solutions, such as room-temperature-stable sealing patches, to enhance bleeding control, streamline operating-room readiness, and address challenges associated with cold-chain storage. Room-temperature sealing patches refer to next-generation hemostatic pads engineered to maintain full functionality without refrigeration, offering greater flexibility, faster deployment, and improved accessibility compared with traditional refrigerated or bulky sponge-based hemostats. For instance, in May 2025, Baxter International Inc., a US-based healthcare company, introduced the Hemopatch Sealing Hemostat RT, its latest collagen-based patch designed for efficient hemostasis in both open and minimally invasive procedures. The patch integrates a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon contact with fluids, enabling rapid tissue adhesion and sealing while promoting natural platelet activity. Offering hemostasis typically within about two minutes, biocompatibility, and full resorption within 6–8 weeks, the product also delivers practical advantages such as room-temperature storage and an extended 36-month shelf life, improving surgical workflow and supply-chain flexibility.What Are Latest Mergers And Acquisitions In The Surgical Hemostats Market?
In May 2025, Merit Medical Systems, Inc., a US-based medical devices company, acquired Biolife Delaware for $120 million. With this acquisition, Merit Medical Systems aims to expand its hemostasis product portfolio and strengthen its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device company that develops surgical hemostatic products.Regional Outlook
North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Surgical Hemostats Market?
The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Surgical Hemostats Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.2 billion |
| Revenue Forecast In 2035 | $5.41 billion |
| Growth Rate | CAGR of 6.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Formulation, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Surgical Hemostats Market Report 2026 market was valued at $3.93 billion in 2025, increased to $4.2 billion in 2026, and is projected to reach $5.41 billion by 2030.
request a sample hereThe expected CAGR for the Surgical Hemostats Market Report 2026 market during the forecast period 2025–2030 is 6.5%.
request a sample hereMajor growth driver of the market includes: The Rise In Trauma Cases Drives The Growth Of The Market Due To Increasing Surgical Interventions in the Surgical Hemostats Market Report 2026 market. For further insights on this market,
request a sample hereThe surgical hemostats market covered in this report is segmented –
1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments:
1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge
2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables
3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets
4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives
5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin
6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin
7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents
request a sample here1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments:
1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge
2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables
3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets
4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives
5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin
6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin
7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents
Major trend in this market includes: Advancements In Room-Temperature Hemostatic Patch Technologies Improve Surgical Bleeding Control And Workflow Efficiency For further insights on this market,
request a sample hereMajor companies operating in the Surgical Hemostats Market Report 2026 market are Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH
request a sample hereNorth America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here